The con side to broad spectrum antibiotics in #sepsis #sepsis19: One potential and older example - Double coverage in febrile neutropenic patient associated with worse outcomes https://t.co/tMSPyj8NqL #CCC48 #CritCareControversies
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia http://t.co/0A8NiBgWyV
Beta-lactam monotherapy for cancer patients with neutropenia is better than combination therapy http://t.co/bsEmveAiDp #CochraneEvidence
Beta-lactam monotherapy for cancer patients with neutropenia is better than combination therapy http://t.co/bsEmveAiDp #CochraneEvidence
Beta-lactam monotherapy for cancer patients with neutropenia is better than combination therapy http://t.co/bsEmveAiDp #CochraneEvidence
Beta-lactam monotherapy for cancer patients with neutropenia is better than combination therapy http://t.co/bsEmveAiDp #CochraneEvidence
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia http://t.co/fvidq9U1RH
Cancer patients with fever & suspected infection can be treated with single 'new-generation' beta-lactam antibiotic http://t.co/iA0lSDNYhq
Updated Cochrane Rev Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer pts with neutropenia http://t.co/zFomceJmqd